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Vitamin A deficiency continues to be a major public health 
problem in developing countries, and is estimated to affect 
about 127 million preschool children and more than 7.2 million 
pregnant women worldwide.1 According to the World Health 
Report of 2002,2 the global prevalence of vitamin A deficiency in 
children aged 0 - 4 years was about 21% and the prevalence of 
night blindness in pregnant women 5%, both being highest in 
Asia and Africa.2,3
Vitamin A is essential for maintaining normal vision, gene 
expression, reproduction, embryonic development, growth 
and immune function.4 The clinical manifestation of vitamin A 
deficiency is xerophthalmia, a collective term for abnormalities 
that can range from night blindness in its mildest form to 
permanent blindness in its most severe form.5 The systemic 
consequences of vitamin A deficiency, viz. increased rate of 
infection-related morbidity and mortality, may however begin 
to occur long before ocular signs of clinical deficiency are 
evident.6 In settings where vitamin A deficiency is prevalent, 
vitamin A supplementation has been shown to result in a 
30% reduction in all-cause mortality7 as well as reductions in 
morbidity. The morbidity conditions particularly beneficially 
affected by the amelioration of vitamin A deficiency are 
diarrhoeal diseases, respiratory disease and measles.8,9 
 The main cause of vitamin A deficiency is a chronic 
inadequate intake of vitamin A-rich foods such as eggs, milk 
and liver,10 as well as the poor bio-availability of β-carotene 
from dark green and yellow vegetables or fruit.11 Repeated 
infections may, however, also contribute towards the depletion 
of vitamin A stores,12 especially when accompanied by fever.13,14 
Serum vitamin A levels are also known to be low in individuals 
infected with HIV.15 Vitamin A status can also be affected by 
heavy loads of parasitic infestations such as Ascaris lumbricoides 
and Giardia lamblia,16,17 which may interfere with the absorption 
of vitamin A. 
Serum retinol is the indicator most widely used for assessing 
vitamin A status. Although there is no direct evidence of 
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Objectives. To estimate the burden of disease attributable to 
vitamin A deficiency in children aged 0 - 4 years and pregnant 
women aged 15 - 49 years in South Africa in 2000.  
Design. The framework adopted for the most recent World 
Health Organization comparative risk assessment (CRA) 
methodology was followed. Population-attributable fractions 
were calculated from South African Vitamin A Consultative 
Group (SAVACG) survey data on the prevalence of vitamin A 
deficiency in children and the relative risks of associated health 
problems, applied to revised burden of disease estimates for 
South Africa in the year 2000. Small community studies were 
used to derive the prevalence in pregnant women. Monte Carlo 
simulation-modelling techniques were used for the uncertainty 
analysis. 
Setting. South Africa.
Subjects. Children under 5 years and pregnant women 15 - 49 
years.
Outcome measures. Direct sequelae of vitamin A deficiency, 
including disability-adjusted life years (DALYs), as well as 
mortality associated with measles, diarrhoeal diseases and 
other infections, and mortality and DALYs associated with 
malaria in children and all-cause maternal mortality.
Results. One-third of children aged 0 - 4 years and 1 - 6% of 
pregnant women were vitamin A-deficient. Of deaths among 
young children aged 0 - 4 years in 2000, about 28% of those 
resulting from diarrhoeal diseases, 23% of those from measles, 
and 21% of those from malaria were attributed to vitamin A 
deficiency, accounting for some 3 000 deaths. Overall, about 110 
467 (95% uncertainty interval 86 388 - 136 009) healthy years of 
life lost, or between 0.5% and 0.8% of all DALYs in South Africa 
in 2000 were attributable to vitamin A deficiency.
Conclusions. The vitamin A supplementation programme 
for children and the recent food fortification programme 
introduced in South Africa in 2003 should prevent future 
morbidity and mortality related to vitamin A deficiency. 
Monitoring the effectiveness of these interventions is strongly 
recommended. 
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the level at which functional consequences of vitamin A 
deficiency (i.e. morbidity and mortality) begin to occur, serum 
concentrations below 20 µg/dl (0.70 µmol/l) are conventionally 
used to indicate inadequate status,18 and serum retinol 
concentrations below 10 µg/dl (0.35 µmol/l) may be associated 
with ocular signs of vitamin A deficiency. At a population 
level vitamin A deficiency is considered to be a significant 
public health problem when more than 15% of that population 
present with serum retinol concentrations below 20 µg/dl.6 
However, because clinical and subclinical infection may have 
a transient lowering effect on serum retinol concentrations, it 
is recommended that infection status also be measured when 
vitamin A status is assessed so that overestimation of the 
prevalence of vitamin A deficiency is avoided.19
According to a national survey conducted in 1994/95 (South 
African Vitamin A Consultative Group (SAVACG)),20 33% of 
children aged 6 - 71 months in South Africa have serum retinol 
concentrations below 20 µg/dl, which is higher than the global 
average estimate of 21% for that age group. The prevalence 
varies from province to province and ranges from 18.5% to 
43.5%, with the Limpopo and KwaZulu-Natal provinces being 
most severely affected. Children living in rural areas and 
whose mothers are poorly educated are also more affected. 
There are no national data on the prevalence of vitamin A 
deficiency in pregnant women. However, ad hoc studies suggest 
that prevalence in this population group ranges from 1% to 
6%.21,22,23 These figures are comparable with global estimates.
The global risk factor assessment found that 0.8 million 
(1.4%) of deaths worldwide are due to vitamin A deficiency,2 
and that 1.8% of the global burden of disease measured in 
disability-adjusted life years (DALYs) can be attributable to 
this deficiency. The aim of the present study was to estimate 
the burden of disease in South Africa attributable to vitamin A 
deficiency in children 0 - 4 years of age and pregnant women 
in 2000.  
Methods 
Comparative risk assessment (CRA) methodology developed 
by the World Health Organization (WHO)2,24 was used. The 
amount of disease burden attributable to exposure to vitamin 
A was estimated by comparing the current observed level 
of vitamin A deficiency with a counterfactual risk factor 
distribution conferring the lowest possible population risk (the 
theoretical minimum distribution). For vitamin A deficiency the 
theoretical minimum was defined by the absence of vitamin A 
deficiency in the population.2,3 
Vitamin A deficiency itself appears as an underlying cause 
of death and disability in the South African burden of disease 
list.25 Although there were no deaths in South Africa in 2000 
directly ascribed to vitamin A deficiency, a considerable non-
fatal component was estimated for this condition, measured 
in years of life lived with disability (YLDs) through the direct 
effects of vitamin A deficiency and its sequelae in all age 
groups. Following the framework developed by Rice et al.,3 
the contribution of vitamin A deficiency to child mortality 
and morbidity can also be measured indirectly through its 
contribution as a risk factor for several diseases, and added to 
the direct effects of vitamin A deficiency.  
The health outcomes assessed were based on those selected 
by the WHO international expert collaborating group on 
vitamin A deficiency.3 They were restricted to those outcomes 
included in the 2000 Global Burden of Disease Study,26,27 
and where data were available to quantitatively estimate 
the relationship with vitamin A deficiency. These included 
childhood mortality associated with measles, diarrhoeal 
diseases, malaria and other infectious diseases (which captures 
the contribution of many low-incidence causes of death under 
one category), all-cause maternal mortality and childhood 
morbidity from malaria. HIV/AIDS was excluded as a 
quantifiable health outcome since the strength of the evidence 
was considered insufficient to demonstrate a causal link or to 
estimate the associated risk with this outcome. Blindness was 
also excluded as a health outcome because vitamin A-related 
blindness is considered to be a direct functional outcome of the 
deficiency. Hence, the disability associated with blindness is 
included in vitamin A deficiency YLDs following the method of 
Murray et al.26,27 
Prevalence of vitamin A deficiency was defined as low serum 
retinol concentrations (< 0.70 µmol/l or < 20 µg/dl) among 
children aged 0 - 4 years and among pregnant women (aged  
15 - 49 years).3 The data source used for prevalence of exposure 
in children was the SAVACG national survey of 1995, which 
presented data for a nationally representative sample of 
children aged 6 - 71 months20 although white children may 
have been underrepresented. The SAVACG data were re-
analysed to estimate the prevalence of vitamin A deficiency 
in children 0 - 4 years of age. In the absence of national data, 
the prevalence of vitamin A deficiency in pregnant women 
in South Africa was estimated from data from 3 studies: 
Dannhauser et al.21 (2000), Dhansay et al.22 (2001) and Dhansay 
et al.23 (1994). In the Dannhauser et al.21 study, a sample of 206 
mainly black African women from low-income groups in the 
second and third trimesters of pregnancy yielded a prevalence 
of 1% for the whole group. In a cohort of 300 women of 
mixed ethnic descent at various stages of pregnancy from a 
low-income suburb of Cape Town, the percentage that were 
vitamin A-deficient (< 0.70 µmol/l or < 20 µg/dl) was 1.9% 
at less than 20 weeks’ gestation and 1.1% between 28 and 34 
weeks’ of pregnancy.22  A cross-sectional study of 105 pregnant 
women in the third trimester in the same community showed 
the prevalence of vitamin A deficiency to be 6%.23  Since the 
global average prevalence of serum retinol concentrations of < 
0.70 µmol/l among pregnant women was estimated at 5.6%,3 
we carried out uncertainty analysis using a range of 1 - 6% for 
pregnant women (see uncertainty analysis below).
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Relative risks (RRs) used for each health outcome were 
those estimated for the global CRA project3 based on a 
comprehensive review of the literature and meta-analyses of 
randomised placebo-controlled vitamin A supplementation 
trials in women and children. These are shown in Table I, 
expressed as the inverse of the protective effect adjusted for 
baseline prevalence of serum retinol concentrations of   < 0.70 
µmol/l in trial populations.28,29 Since RR estimates for child 
and maternal health outcomes used vitamin A intervention 
trial data as the starting point, the RRs were adjusted using a 
4-step process to take into account the fact that many, but not 
all, study participants had low serum concentrations at the 
beginning of the intervention trials.3
Population-attributable fractions by age and cause were 
calculated in MS Excel using the formula: 
where P is the prevalence of exposure and RR is the relative 
risk of disease in the exposed versus unexposed group. The 
population-attributable fractions were then applied to the 
revised South African burden of disease estimates for deaths 
and DALYs for 2000.25
Monte Carlo simulation-modelling techniques were used to 
present uncertainty ranges around point estimates that reflect 
all the main sources of uncertainty in the calculations. The @
RISK software version 4.5 for Excel31 was used, which allows 
multiple recalculations of a spreadsheet each time choosing 
a value from distributions defined for input variables. The 
probability distributions around the input variables were based 
on standard errors of the prevalence for children aged 0 - 4 
years from the SAVACG data.20 For the prevalence of vitamin 
A deficiency among pregnant women, a uniform probability 
distribution was specified, with a minimum of 1% and a 
maximum of 6% (yielding a midpoint estimate of about 3.5%). 
For the RR input variables a normal distribution was specified, 
with the natural logarithm of the RR estimates as the entered 
means of the distribution and standard errors derived from 
the published 95% confidence intervals.3 The 95% uncertainty 
ranges were calculated for the output variables, namely 
attributable burden as a percentage of total burden in South 
Africa in 2000 (bounded by the 2.5th and 97.5th percentiles of 
the 2000 iteration values generated). 
Table I. Adjusted relative risks (RRs) of adverse health outcomes associated with vitamin A deficiency 
  RR* associated with vitamin A deficiency
Health outcome ICD-9 codes30              RR                         95% CI
Children (0 - 4 years)
Diarrhoeal disease mortality 001, 002, 004, 006-009             2.1528                    1.83 - 2.58
Measles mortality 055             1.8628                    1.32 - 2.59
Malaria incidence 084             1.7829                    1.43 - 2.19
Malaria mortality  084             1.7829                    1.43 - 2.19
Selected other infectious disease causes of mortality  003, 005, 020-027, 031, 034, 035,              1.1328                    1.01 - 1.32 
038†-041, 046-049, 051-054,  
057, 060-066, 071-079, 080-083,  
087, 088, 100-104,110-118, 121-124,  
130-136, 139
Pregnant women (15 - 44 years‡)
All-cause maternal mortality 630-676             4.5129                    2.91 - 6.94
Source: Adapted from Rice et al.3 
*Adjusted for baseline prevalence of serum retinol concentrations < 0.70 µmol/l in trial population. 
†038 Septicaemia; listed separately on the South African burden of disease list but included in this category for this analysis. 
‡Attributable fractions calculated for women 15 - 49 years.  
ICD-9 = International Classification of Diseases, 9th revision.
Table II. Population attributable fractions and burden attributable to vitamin A deficiency in children 0 - 4 years, South Africa, 
2000
Related outcomes PAF (%) Attributable deaths Attributable DALYs
Diarrhoeal diseases (mortality)    28             2 972            99 975
Measles (mortality)    23                  44               1 488
Other infectious diseases (mortality)      4                  45              1 506
Malaria (mortality and morbidity)    21                    8                  262
Vitamin A deficiency  100                    0                  460
Total attributable burden               3 069          103 691
PAF = population-attributable fraction; DALYs = disability-adjusted life years.
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Results 
The prevalence of vitamin A deficiency 
in South African children aged 0 - 4 
years was estimated at 33.8% using 
the SAVACG national data, which 
means that 1.8 million children were 
affected in 2000. For pregnant women, 
prevalence of vitamin A deficiency was 
estimated to be fairly low at 1%, but 
we used a range of 1 - 6% (midpoint 
3.5%) for our calculations affecting 
about 38 500 births.  
The population-attributable fractions 
(PAFs) for the selected health outcomes 
as well as the estimated number of 
cause-specific deaths and DALYs 
attributed to vitamin A deficiency 
among children aged 0 - 4 years 
are shown in Table II.  PAFs ranged 
from 4% of mortality from other 
infectious diseases to 28% of mortality 
from diarrhoeal diseases. All (100%) 
vitamin A deficiency YLDs were 
attributed to vitamin A deficiency. Of 
3 069 deaths in children attributed to 
vitamin A deficiency, the vast majority 
(N = 2 972) were due to diarrhoeal 
diseases.  Diarrhoeal diseases 
accounted for 96.9% of all attributable 
deaths, while malaria (0.2%), other 
infectious diseases (1.5%) and measles 
(1.4%) accounted for much smaller 
proportions of total vitamin A-
attributable deaths in children 0 - 4 
years of age (Fig. 1).  
About 11% of all maternal mortality 
(222 deaths) was attributed to vitamin 
A deficiency. In addition to estimating 
the preventable deaths, attempts were 
also made to estimate attributable 
disease burden in children 0 - 4 years 
of age and pregnant women. Overall, 
between 86 388 and 136 009 DALYs 
(0.5 - 0.8% of all healthy years of life 
lost (YLLs) in South Africa in 2000) 
were associated with vitamin A 
deficiency (Table III). Results of the 
uncertainty analysis are also presented 
in the table.
Discussion 
Vitamin A deficiency is a public 
health problem among preschool 
children in South Africa, with 33.8% 
of children aged 0 - 4 years being 
vitamin A-deficient. The results of this 
study suggest that in 2000 about 28% 
of deaths from diarrhoeal diseases, 
23% of those from measles and 21% 
of those from malaria in children 
aged 0 - 4 years could be attributed 
to vitamin A deficiency. In addition, 
4% of mortality from other infectious 
diseases in children aged 0 - 4 years 
was also attributable to this risk factor. 
Vitamin A deficiency accounted for 
3 069 deaths in children aged 0 - 4 
years (3.2% of all deaths in this age 
group). Predisposing children to risk 
of mortality from diarrhoeal diseases 
is the major consequence of vitamin 
A deficiency, accounting for 96.9% of 
the childhood deaths attributable to 
vitamin A deficiency. This is much 
higher than the estimated 50% from 
the global study, in which malaria 
and measles played a larger role. The 
burden from measles and malaria 
is relatively small in South Africa, 
probably reflecting good disease 
prevention and control for these 
conditions. 
Despite assuming that women who 
were vitamin A-deficient had a 4.5-fold 
increased risk of maternal mortality 
compared with non-deficient women, 
only about 11% of maternal mortality 
in South Africa could be attributed to 
this risk factor. This is also lower than 
the estimated 20% of maternal deaths 
worldwide, and is a result of the 
relatively low prevalence of vitamin A 
deficiency among pregnant women in 
South Africa. 
Overall, an estimated 110 467 (95% 
uncertainty interval 86 388 - 136 009) 
healthy YLLs, or between 0.5% and 
0.8% of all DALYs in South Africa in 
2000, are attributable to vitamin A 
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deficiency. This risk factor is ranked 14th overall in terms of 
DALYs for 17 risk factors assessed in South Africa, ranking 
lower than ‘underweight’ and other forms of micronutrient 
deficiencies such as iron-deficiency anaemia. Vitamin A is an 
important risk factor in children, ranking fourth overall and 
accounting for 2.5% (2.0 - 3.1%) of all healthy YLLs in children 
aged 0 - 4 years. 
Given the high prevalence of HIV in South Africa, it is 
important to consider the possible role of vitamin A deficiency 
in HIV-related morbidity and mortality.  Studies have shown 
that there is increased infant mortality in children born to HIV-
positive mothers with vitamin A deficiency, and there is also a 
strong association between low serum retinol and CD4 counts 
for both seropositive and seronegative individuals.32 Although 
the role of vitamin A supplementation to prevent mother-to-
child transmission of HIV is unclear, and WHO guidelines 
raise concerns about the safety of vitamin A supplementation 
programmes, data show that vitamin A deficiency is more 
prevalent among HIV-positive persons than HIV-negative 
individuals.33  
Research has shown the importance of optimal nutritional 
status of an individual in the progression from HIV to AIDS.33 
According to Kafwembe et al.,34 vitamin A concentration is 
lowered in HIV infection and therefore the depletion of vitamin 
A appears to increase with progression of the infection leading 
to AIDS infection, and it delays recovery from other infections. 
Our estimate is likely to be an underestimation of the 
attributable burden due to vitamin A deficiency, since we have 
not quantified this impact. Furthermore, HIV/AIDS accounts 
for 40% of the total mortality in children aged 0 - 4 years, thus 
reducing the relative size of other conditions.  
A report in 200235 showed that nationally, 35% of the clinics 
routinely administer vitamin A to HIV-positive children, and 
that of the 130 clinics where vitamin A is dispensed, less than 
one-quarter prescribe the correct regimen for HIV-infected 
children. According to the report, vitamin A supplementation 
in HIV-infected children was associated with reduced 
morbidity, particularly in relation to diarrhoeal disease, 
reduced mortality and improved immune function. Whether 
regular supplementation of vitamin A to the HIV-infected 
individual can lead to an altered progression to AIDS needs to 
be explored.35 
In view of the role of infection in reducing the level of 
serum retinol,19 it is possible that survey results overstate the 
true extent of vitamin A deficiency. This was not considered 
to be the case in the national SAVACG survey, since children 
with acute fever were excluded. The burden of disease 
attributable to vitamin A deficiency estimated in the present 
study was based on data from the SAVACG study, which were 
collected in 1994.20 Since then, however, several interventions 
have been introduced in South Africa. A high-dose vitamin 
A supplementation programme targeting all children aged 
6 months - 5 years and postpartum women within 4 - 8 
weeks of delivery was introduced in 2002.36,37 A national food 
fortification programme, whereby maize meal and wheat flour 
are fortified with several vitamins and minerals including 
vitamin A, was introduced in 2003.38 The current levels of 
vitamin A deficiency could therefore be very different.  
A national survey on the micronutrient status of preschool 
children and women is currently underway, and when these 
data become available it is suggested that the risk attributed 
to vitamin A deficiency be recalculated and the situation re-
evaluated. 
Conclusion and recommendations
Because supplementation and food fortification programmes 
have already been introduced in South Africa, operational 
research to monitor the effective implementation of 
these interventions and assessment of their impact are 
recommended. The possible negative consequences of blanket 
supplementation with high-dose vitamin A capsules in children 
who are not vitamin A-deficient should also be borne in 
mind.39
Another strategy that should not be ignored is that of dietary 
diversification. This is a long-term approach and should be 
the ultimate goal of any campaign to control micronutrient 
deficiencies. A project that focuses on home gardening and 
encourages the production and consumption of β-carotene-rich 
foods has, for instance, been successfully implemented in a 
rural area of KwaZulu-Natal, and was shown to significantly 
Fig. 1. Deaths attributable to vitamin A deficiency in children 0 - 4 years, 
South Africa, 2000
Attributable Deaths = 3 069
Children 0-4 years
Diarrhoeal diseases
96.9%
Other infectious diseases
1.5%
Measles
1.4%
Malaria
0.3%
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improve vitamin A status of the preschool children in the 
area.40  
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